Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zaffirios Zygouras Insider Profile
4 Followers
Zaffirios Zygouras, Senior Officer at Neupath Health Inc., holds 26.13K shares in Neupath Health Inc. (Ticker: TSE:NPTH).
Zaffirios Zygouras has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Zaffirios Zygouras's holdings
Insider Roles
Senior Officer
Roles that Zaffirios Zygouras holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Zaffirios Zygouras
Zaffirios Zygouras's Trading History
List of latest transactions for each holding click on a transaction to see Zaffirios Zygouras's performance on stock
You May Also Like
Zaffirios Zygouras insider profile FAQ
What is the percentage of profitable transactions made by Zaffirios Zygouras?
The percentage of profitable transactions made by Zaffirios Zygouras is ―.
What is the average return per transaction made by Zaffirios Zygouras?
The average return per transaction made by Zaffirios Zygouras is ―.
What stocks does Zaffirios Zygouras hold?
Zaffirios Zygouras holds: TSE:NPTH stocks.
What was Zaffirios Zygouras’s latest transaction?
Zaffirios Zygouras latest transaction was an Uninformative Sell of C$756.00.
What was Zaffirios Zygouras's most profitable transaction?
Zaffirios Zygouras’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Zaffirios Zygouras's role in Neupath Health Inc.?
Zaffirios Zygouras's role in Neupath Health Inc. is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.